ArticleBritish journal of haematology2017

A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).

Susan R Rheingold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.